Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $15.8250 (2.06%) ($15.8250 - $15.8250) on Wed. Jun. 30, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.7% (three month average) | RSI | 39 | Latest Price | $15.8250(2.06%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.5% a day on average for past five trading days. | Weekly Trend | BCRX declines -0.7% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(45%) IBB(40%) IWO(37%) ARKK(36%) ARKG(35%) | Factors Impacting BCRX price | BCRX will decline at least -2.35% in a week (0% probabilities). VIXM(-23%) UUP(-15%) VXX(-7%) IGOV(-2%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.35% (StdDev 4.7%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
Resistance Level | $16.47 | 5 Day Moving Average | $16.2(-2.31%) | 10 Day Moving Average | $16.36(-3.27%) | 20 Day Moving Average | $16.47(-3.92%) | To recent high | -8.2% | To recent low | 66.7% | Market Cap | $2.792b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |